Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.8100 (3.53%) ($8.8100 - $8.8100) on Thu. Jan. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.79% (three month average) | RSI | 46 | Latest Price | $8.8100(3.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(70%) IBB(56%) IWC(52%) IWM(48%) IWO(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.395% in a week (0% probabilities). VIXM(-16%) SMH(-8%) UUP(-7%) TBT(-5%) USO(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.395% (StdDev 4.79%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.83(-132.12%) | Resistance Level | $8.97 | 5 Day Moving Average | $8.56(2.92%) | 10 Day Moving Average | $8.71(1.15%) | 20 Day Moving Average | $8.97(-1.78%) | To recent high | -33.4% | To recent low | 7.2% | Market Cap | $547m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |